Skip to main content
. 2017 Sep 12;35(38):5194–5200. doi: 10.1016/j.vaccine.2017.07.104

Table 6.

Adverse events occurred in the 24 h after immunization in individuals vaccinated with Euvichol® during the November-December OCV campaign in a 2 km (N = 718) and 25 km (N = 1548) radius of Lake Chilwa, Malawi, December 2016.

Population living in 2 km radius
Population living in 25 km radius
N % N %
Adverse events in the 24 h following immunization
Yes 43 5.0 [0.1–9.8] 52 3.4 [1.5–5.3]
Yes, one 43 6.0 51 3.3
Yes, two 0 NA 1
Not reported 2 0.3 0 NA



Symptoms
Nausea 39 90.7 36 69.2
Diarrhea 2 4.7 8 15.4
Vomiting 2 4.7 1 1.9
Abdominal pain 0 NA 3 5.8
Weakness 0 NA 2 3.9
Headache 0 NA 1 1.9
Fever 0 NA 1 1.9



After which dose
Dose 1 42 97.7 36 69.2
Dose 2 1 2.3 15 28.9
Not reported 0 NA 1 1.9



Health center attendance if adverse event
Yes 2 4.7 1 1.9
Not reported 0 NA 6 11.5

NA: Not applicable.